Holter ECG Market Analysis

Holter ECG Market Analysis

Based on product type, the Holter ECG market is segmented as continuous monitors and intermittent monitors. The continuous monitors segment was valued at over USD 846 million in 2022. This driven by significant technological advancement and an increase in the awareness of benefits related to the use of continuous Holter ECG monitors. The biggest advantage of a Holter monitor is that it is a portable & wearable device that can be easily worn by patients for a specified amount of time while continuing with their routine activities. These devices are highly recommended by doctors to track the heart’s rhythm during routine tasks or hospitalization.
 

As per the research studies, continuous Holter ECG monitoring can serve as a diagnostic tool for several cardiac conditions including atrial fibrillation, ventricular tachycardia, and cardiac arrhythmias among others. Moreover, according to the Cardiovascular Institute of America, one of the key advantages of this device is that it’s non-invasive as there are no incisions or breaks in patients skin and shows every heartbeat that can be the cause of cardiac disease. In the coming years, the popularity of Holter ECG monitors will produce even greater amounts of data in real-time through the integration of big data and artificial intelligence that will effectively reduce the mortality of CVD.
 

Based on modality, the Holter ECG market is segmented as wired Holter monitors and wireless Holter monitors. The wired Holter monitors segment surpassed USD 1 billion in 2022. This is owing to the growing technological advancements in wired Holter monitors, increase in R&D activities, and surging adoption of minimally invasive devices among others. The new generations Holter ECG devices are allowing the direct transmission of remote cardiac monitoring data.
 

Market players are focusing on the designing of sleek & efficient recorder for patient comfort & for streamlined workflow as per the individual patient requirements. Improving set-up features comprising simple navigation buttons, large on-board display, automatic power on self-test, and lightweight design is assisting in faster operation along with enhanced comfort. Intelligent Holter monitors are helping to detect irregular heartbeat that are difficult to identify at regular check-ups. AI-ECG analysis is transforming the cardiac monitoring area through fragmenting to analysing data and generating reports.  
 

Based on end-use, the Holter ECG market is segmented as hospitals, ambulatory surgical centers, and others. The hospitals segment is projected to reach more than USD 2 billion by 2032. The soaring use of novel wearable cardiac devices in hospital settings delivering rapid and reliable outcomes is estimated to surge the patient preference for these healthcare facilities. The availability of a broad spectrum of Holter ECG recorder that supports continuous monitoring with proven accuracy is set to drive product preference in hospitals. Growing admissions with cardiac ailments and growing disease screening initiatives along with the accessibility to board-certified healthcare professionals are some other variables that are augmenting the segment growth positively.
 

Furthermore, the rising disease burden in developed economies with enhanced healthcare infrastructure is projected to stimulate the diagnosis & treatment rate at hospitals. As a result, accessibility to an effective precise cardiac monitoring coupled with the rising prevalence of cardiovascular diseases and associated conditions will boost the patient visits to hospitals.

The U.S. dominated the North America Holter ECG market with a significant market share in 2022 and is anticipated to expand at a considerable pace to reach USD 1,480 million by 2032. This majority market share is attributed to several factors such as the presence of major industry players, an upsurge in the demand for cardiovascular continuous monitoring services, rise in the prevalence of cardiovascular conditions, and growing number of hospital admissions across the country among others. As per the American Heart Association data 2022, the age adjusted death-rate attributable to cardiovascular diseases was 224.4 per 100,000 population.
 

Moreover, the U.S. is one of the leading nations in terms of heart care initiatives and the government has employed several guidelines to bolster heart comprising the Million Hearts initiative. These initiatives adopted by the public as well as private organizations would further promote the demand for Holter ECG to maintain precise heart health and physical & mental wellbeing among cardiac patients.